328
Participants
Start Date
January 31, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Symbicort Turbuhaler (Budesonide/formoterol)
2 x 160/4.5 microgram, inhalation, bid, 52 weeks
Drug: any available COPD treatment; investigator to decide
According to investigator decision, 52 weeks, Standard COPD treatment according to investigator decision
Research Site, Nagoya
Research Site, Toyota
Research Site, Yanagawa
Research Site, Hiroshima
Research Site, Asahikawa
Research Site, Sapporo
Research Site, Itami
Research Site, Hitachi
Research Site, Tsukuba
Research Site, Sakaidechō
Research Site, Fujisawa
Research Site, Yokohama
Research Site, Kōshi
Research Site, Kyoto
Research Site, Murata
Research Site, Chūō
Research Site, Setagaya City
Lead Sponsor
AstraZeneca
INDUSTRY